Cargando…
Evaluating Biomarkers for Guiding Treatment Decisions
The genetic revolution is expected to lead to improved targeting of new and existing forms of treatment. Rather than a one-size-fits-all blockbuster strategy in battling disease with drugs and other interventions, a more precise approach is becoming available, one in which treatment is only offered...
Autores principales: | Bossuyt, Patrick M., Parvin, Tajik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4975224/ https://www.ncbi.nlm.nih.gov/pubmed/27683482 |
Ejemplares similares
-
Development and evaluating multimarker models for guiding treatment decisions
por: Tajik, Parvin, et al.
Publicado: (2018) -
Genomic markers to tailor treatments: waiting or initiating?
por: Tajik, Parvin, et al.
Publicado: (2011) -
Practical guide for identifying unmet clinical needs for biomarkers
por: Monaghan, Phillip J., et al.
Publicado: (2018) -
An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision
por: Lorenzin, Mariagrazia, et al.
Publicado: (2020) -
The Role of Biomarkers in Guiding Clinical Decision-Making in Oncology
por: Moore, Donald C., et al.
Publicado: (2023)